These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1348 related items for PubMed ID: 18849202

  • 1. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR, Pressler T, Hoiby N, Johansen HK.
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [Abstract] [Full Text] [Related]

  • 2. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [Abstract] [Full Text] [Related]

  • 3. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ, Tiddens HA, Verbrugh HA, Ott A.
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [Abstract] [Full Text] [Related]

  • 4. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 5. Macrolide-resistant Staphylococcus aureus colonization in cystic fibrosis patients: is there transmission to household contacts?
    Tramper-Stranders GA, van der Ent CK, Gerritsen SA, Fleer A, Kimpen JL, Wolfs TF.
    J Antimicrob Chemother; 2007 Sep; 60(3):665-8. PubMed ID: 17604321
    [Abstract] [Full Text] [Related]

  • 6. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR, Pressler T, Koch C, Høiby N.
    J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 8. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
    Vergison A, Denis O, Deplano A, Casimir G, Claeys G, DeBaets F, DeBoeck K, Douat N, Franckx H, Gigi J, Ieven M, Knoop C, Lebeque P, Lebrun F, Malfroot A, Paucquay F, Pierard D, Van Eldere J, Struelens MJ.
    J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study.
    Jacobs MR, Bajaksouzian S, Windau A, Good CE, Lin G, Pankuch GA, Appelbaum PC.
    Clin Lab Med; 2004 Jun; 24(2):503-30. PubMed ID: 15177851
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE, Lindmark A, Persson I.
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract] [Full Text] [Related]

  • 16. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
    Dorfman MS, Wagner RS, Jamison T, Bell B, Stroman DW.
    Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
    [Abstract] [Full Text] [Related]

  • 17. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H, Takeda H, Kawai S, Watanabe S, Okazaki M, Shimada K, Nakano K, Yokouchi H, Mori T, Igari J, Oguri T, Yamamoto M, Kudo K, Kobayashi N, Tanaka T, Yoshimura K, Kawabata M, Nakamori Y, Sumitomo M, Inoue H, Nakadate T, Suwabe A, Ashino Y, Aoki N, Honma Y, Suzuki Y, Karasawa Y, Oka M, Kobashi Y, Kohno S, Hirakata Y, Kondou A, Matsuda J, Nakano M, Oikawa S.
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [Abstract] [Full Text] [Related]

  • 18. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE.
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [Abstract] [Full Text] [Related]

  • 19. Pharyngeal colonization and drug resistance profiles of Morraxella catarrrhalis, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae among HIV infected children attending ART Clinic of Felegehiwot Referral Hospital, Ethiopia.
    Mulu W, Yizengaw E, Alemu M, Mekonnen D, Hailu D, Ketemaw K, Abera B, Kibret M.
    PLoS One; 2018 Sep; 13(5):e0196722. PubMed ID: 29746496
    [Abstract] [Full Text] [Related]

  • 20. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H, Ito C, Yoshida T, Watanabe K, Mori T, Ohno I, Okada S, Igari J, Arakawa M, Igarashi K, Oguri T, Okada M, Ozaki K, Terai T, Aoki N, Inoue H, Nakadate T, Kitamura N, Sekine O, Suzuki Y, Ando M, Suga M, Sato K, Nakata K, Kusano N.
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.